scholarly journals Glaucoma and the dry eye syndrome

2014 ◽  
Vol 7 (2) ◽  
pp. 37-49 ◽  
Author(s):  
Vladimir Vsevolodovich Brjesky ◽  
Mukhammed Radukhan
Keyword(s):  
Dry Eye ◽  
Beta Blockers ◽  
Dry Eye Syndrome ◽  
Pharmacological Effect ◽  
Toxic Action ◽  
Review Of The Literature ◽  
Treatment Methods ◽  
Prevention And Treatment ◽  
Preservative Free ◽  
Corneal Trauma

The development of the dry eye syndrome in glaucoma patients is a pressing challenge during last 10 years. As reported by multiple investigators, the main causes for the development of corneal and conjunctival xerosis in such patients are: toxic action of preservatives in hypotensive ophthalmic medications, pharmacological effect of beta-blockers, and corneal trauma at the time of diagnostic manipulations. A meaningful action to prevent this disease is a to switch to either a preservative-free hypotensive ophthalmic medications, or to those containing a non-toxic preservative. A review of the literature was also done to find the causes, prevention and treatment methods of the dry eye syndrome in glaucoma patients

OKVision ® SMARTFIT™ Scleral Contact Lens Manufacturing Technology

The Eye ◽  
2021 ◽  
Vol 23 (2) ◽  
pp. 47-52
Author(s):  
S. V. Listratov ◽  
N. A. Bakalova ◽  
V. V. Averich
Keyword(s):  
Dry Eye ◽  
Contact Lens ◽  
Conventional Treatment ◽  
Contact Lenses ◽  
Manufacturing Technology ◽  
Eye Diseases ◽  
Dry Eye Syndrome ◽  
Annual Increase ◽  
Treatment Methods

Corneal keratoectasia and dry eye syndrome (DES) are two of the most prevalent eye diseases. A number of studies is being carried out aimed at identifying and analyzing the annual increase in incidence of these diseases in population strata. Treatment and rehabilitation of patients with keratoectasia and DES remain topical issues in modern ophthalmology. Conventional treatment methods are not always effective, and scleral lenses (SCLs) may be considered an alternative. In this article, the authors expand on technology of manufacturing of OKVision® SMARTFIT™ scleral contact lenses.

scholarly journals Analysis of treatment results in dry eye syndrome patients after phacoemulsification by preservative-free 0.3% sodium hyaluronate eye drops

2017 ◽  
Vol 10 (2) ◽  
pp. 73-77
Author(s):  
Yury I Pirogov ◽  
Galina M Butina ◽  
Aleksandr A Oksentjuk ◽  
Ekaterina S Khromova
Keyword(s):  
Dry Eye ◽  
Sodium Hyaluronate ◽  
Dry Eye Syndrome ◽  
Surgical Trauma ◽  
Eye Drops ◽  
Mean Values ◽  
Tear Secretion ◽  
Mild Degree ◽  
Patient Symptom ◽  
Preservative Free

Postsurgical dry eye syndrome is found in a substantial proportion of patients after phacoemulsification. Its onset could be explained by surgical trauma and by use of preservative-containing eye drops. In some patients, it causes substantial discomfort that continues unabated after 3-4 weeks after surgery. Purpose. To investigate the results of 0.3% sodium hyaluronate instillation therapy used to treat dry eye syndrome after phacoemulsification. Materials and methods. Basal tear secretion (Schirmer II test) and tear breakup time (TBUT) test were investigated in 33 patients with symptoms characteristic of dry eye syndrome in 1 month after phacoemulsification. These patients received 0.3% preservative-free sodium hyaluronate instillations for 30 days, whereupon Schirmer II and TBUT tests were repeated. Symptom dynamics was estimated according to the OSDI questionnaire scale. Results. Mean values of basal tear secretion and TBUT tests were slightly below normal ones. In one month of treatment, the TBUT index associated with “Gilan Ultra Comfort” use became somewhat better: mean TBUT value appeared to be 9.8 ± 2.5 sec. OSDI questionnaire patient symptom score evaluation also revealed in patients a mild degree of xerosis severity. Mean score before treatment was 19.6 ± 10.0. Positive disease dynamics after “Gilan Ultra Comfort” use is confirmed by a significant decrease of OSDI score index up to 12.3 ± 6.3.

scholarly journals Use of preservative-free hyaluronic acid (Hylabak®) for a range of patients with dry eye syndrome: experience in Russia

2014 ◽  
pp. 1169 ◽  
Author(s):  
John Stolz ◽  
Vladimir Brjesky ◽  
Yury Maychuk ◽  
Alexey Petrayevsky ◽  
Peter Nagorsky
Keyword(s):  
Hyaluronic Acid ◽  
Dry Eye ◽  
Dry Eye Syndrome ◽  
Preservative Free

Comprehensive Treatment of Dry Eye Syndrome in Patients with Sjogren’s Syndrome by Using Preservative-Free Drops Containing 0.4 % Sodium Hyaluronate and a Complex of Nutraceuticals

2021 ◽  
pp. 8-17
Author(s):  
Oleksandra V. Zborovska ◽  
Ilijna S. Horyanova ◽  
Victoria V. Kolesnichenko
Keyword(s):  
Sjögren’S Syndrome ◽  
Dry Eye ◽  
Sjögren's Syndrome ◽  
Sodium Hyaluronate ◽  
Sjogren’S Syndrome ◽  
Sjogren's Syndrome ◽  
Dry Eye Syndrome ◽  
Comprehensive Treatment ◽  
Preservative Free ◽  
Sjögren‘S Syndrome

The aim. To increase the effectiveness of treatment of dry eye syndrome in patients with Sjogren’s syndrome with preservative-free drops which contain 0.4 % sodium hyaluronate and nutraceutical complexes nutraceuticals. Materials and methods. The study was conducted on the basis of the Filatov Institute of Eye Diseases and Tissue Therapy of the National Academy of Medical Sciences of Ukraine. The study included 64 patients aged 34 to 58 years (128 eyes) with dry eye syndrome accompanied by Sjogren’s syndrome. Examination of patients included: assessment of complaints, visometry, refractometry, bacterial culture of the conjunctiva and nasopharynx, biomicroscopy, ophthalmoscopy, Schirmer and Norn tests, assessment of "comfort of application of drops" on the questionnaire. This study is an extension of the study previously conducted at the premises of the Filatov Institute of Eye Diseases and Tissue Therapy of The National Academy of Medical Sciences of Ukraine on the effectiveness of preservative-free eye drops containing 0.4 % hyaluronic acid in the treatment of Sjogren’s syndrome. Results. Prior to the appointment of comprehensive treatment with instillations, the Norn test showed 6.55 s (SD 1.57) with a minimum of 3 s, a maximum of 9 s, and a median of 6.5 s. After 3 months of treatment the Norn test score in the 1st group averaged 14.66 (SD 1.07) vs. 13.86 (SD 1.07) in the 2nd group, but the difference was not statistically significant (p=1.0). The mean number of required instillations per day was 4.1 (SD 1.04) in the 1st group and 5.27 (SD 1.11) in the 2nd group. Conclusion. Instillations of preservative-free drops containing sodium hyaluronate 0.4 % (in a bottle with an innovative ophthalmic squeeze dispenser (OSD)) in combination with a nutraceutical complex in the treatment of dry eye syndrome in patients with Sjogren’s syndrome is effective and allows achieving a stable and long-term effect. Keywords: Sjogren’s syndrome, hyaluronic acid, nutraceuticals, artificial tear, Schirmer test, Norn test, dry eye syndrome, tear film.

Additive Effect of Preservative-free Sodium Hyaluronate 0.1% in Treatment of Dry Eye Syndrome With Diquafosol 3% Eye Drops

Cornea ◽  
2014 ◽  
Vol 33 (9) ◽  
pp. 935-941 ◽  
Author(s):  
Ho Sik Hwang ◽  
Yoon-mi Sung ◽  
Weon Sun Lee ◽  
Eun Chul Kim
Keyword(s):  
Dry Eye ◽  
Sodium Hyaluronate ◽  
Dry Eye Syndrome ◽  
Additive Effect ◽  
Eye Drops ◽  
Preservative Free

scholarly journals Understanding of Dry Eye Syndrome in Traditional Chinese Medicine

2021 ◽  
Vol 5 (6) ◽  
pp. 32-35
Author(s):  
Jingxiang Chen ◽  
Jingan Tong
Keyword(s):  
Chinese Medicine ◽  
Traditional Chinese Medicine ◽  
Dry Eye ◽  
Dry Eye Syndrome ◽  
Diagnosis And Treatment ◽  
Current Status ◽  
Prevention And Treatment

Explore the current status of Chinese medicine understanding and prevention and treatment of dry eye, so as to improve the efficacy of Chinese medicine in the diagnosis and treatment of dry eye.

scholarly journals Current approaches to prevention and treatment of secondary dry eye syndrome

2017 ◽  
pp. 61-64 ◽  
Author(s):  
E.A. Egorov ◽  
◽  
T.B. Romanova ◽  
E.G. Rybakova ◽  
J.G. Oganezova ◽  
...  
Keyword(s):  
Dry Eye ◽  
Dry Eye Syndrome ◽  
Prevention And Treatment
Sign in / Sign up

Export Citation Format

Share Document